News

Article

Bit Bio’s ‘enter button for keyboard’ nabs the company $41.5 million

Bit Bio raises series A funding for its programming approach to human cells.

23.06.2020

Published by TechCrunch

Bit Bio raises series A funding for its programming approach to human cells.

Published by TechCrunch

Read now

Article

‘Beautiful science’ underpins $41.5m investment in Bit Bio

Discovery Drive-based synthetic biology Bit Bio has closed a $41.5million Series A investment.

16.06.2020

Published by Cambridge Independent

Read now

Press Release

Bit Bio secures $41.5 M of funding from top life sciences investors

bit.bio closes series A $41.5 million funding.

13.06.2020

Published by bit.bio

Read now

Press Release

Bit Bio secures distribution agreement with Abcam

Bit Bio announces agreement with Abcam, to make Bit Bio’s iPSC derived functional human cells widely available.

26.02.2020

Published by PR Newswire

Read now

Press Release

Charles River announces Bit Bio partnership, increasing drug discovery technologies

bit.bio and Charles River announce strategic partnership.

11.12.2019

Published by Business Wire

Read now

Article

Start-up Bit Bio expands leadership team

Paul Morril, Horizon Discovery co-founder joins as CBO and Florian Schuster, Tessa Therapeutics, as CFO.

29.10.2019

Published by BioSpace

Read now

Article

Meet Bit Bio as cell coding firm retires the Elpis Biomed name

Elpis Biomed rebrands to bit.bio.

14.10.2019

Published by Cambridge Independent

Read now

Article

Introducing Bit Bio — coding cells, the building blocks of life.

bit.bio combines the concepts of coding and biology to provide human cells for research, drug discovery and cell therapy.

14.10.2019

Published by Medium

Read now

Article

Mastering the art of reprogramming human cells

Reprogramming human cells by bit.bio.

07.10.2019

Published by Cambridge Independent

Read now

Related pages

Join our pioneering team